Obesity Drugs Are Giving New Life to BMI - The Atlantic

The outdated, much-maligned health measure now determines who gets obesity drugs—and who doesn't.
The outdated, much-maligned health measure now determines who gets obesity drugs—and who doesn’t.

From Ozempic to Wegovy, these were Yahoo's top weight-loss drug

Two brave Atlantic Canadian women transform lives after beating obesity

The Obesity-Drug Era Starts Now - The Atlantic

Healthcare, Free Full-Text

Global market for anti-obesity drugs could reach $100B by 2030: Goldman Sachs

Will Ozempic Change How We Think About Being Fat and Being Thin?

Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK - The Lancet Diabetes & Endocrinology

The Diet Industry Is Pivoting to Ozempic - The Atlantic

The Obesity-Drug Era Starts Now - The Atlantic